BOSTON SCIENTIFIC CORPORATION Proceeds and Excess Tax Benefit from Share-based Compensation
BOSTON SCIENTIFIC CORPORATION (BSX) reported Proceeds and Excess Tax Benefit from Share-based Compensation of $38.00 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-20.
Discontinued › Notes › Compensation Related Costs
us-gaap:ProceedsAndExcessTaxBenefitFromSharebasedCompensation · last filed 2018-02-20
- BOSTON SCIENTIFIC CORPORATION proceeds and excess tax benefit from share-based compensation for the quarter ending 2017-12-31 was $1.00M.
- BOSTON SCIENTIFIC CORPORATION proceeds and excess tax benefit from share-based compensation for the quarter ending 2017-03-31 was $28.00M.
- BOSTON SCIENTIFIC CORPORATION proceeds and excess tax benefit from share-based compensation for fiscal 2017 was $38.00M.
| Period end | Proceeds and Excess Tax Benefit from Share-based Compensation 3 month | Proceeds and Excess Tax Benefit from Share-based Compensation 9 month | Proceeds and Excess Tax Benefit from Share-based Compensation 12 month |
|---|---|---|---|
| 2017-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-20 | $38.00M 10-K · filed 2018-02-20 | |
| 2017-09-30 | $37.00M 10-Q · filed 2017-11-02 | ||
| 2017-03-31 | $28.00M 10-Q · filed 2017-08-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |